Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. ( (AU:IBX) ) has shared an announcement.
Imagion Biosystems Limited has convened its 2026 Annual General Meeting, to be held virtually via webinar on 26 May at 10:00am AEST, reflecting ongoing adoption of online formats for shareholder meetings. The company has shifted to electronic distribution of meeting materials in line with amendments to the Corporations Act, directing investors to its website, the ASX announcements platform and the share registry portal for access.
Shareholders are encouraged to lodge proxies ahead of the meeting, with options to submit votes electronically and participate in the AGM via the virtual platform. The move further embeds digital communication and governance practices within Imagion’s investor relations framework, potentially improving accessibility for both domestic and international shareholders.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited is an Australian life sciences company listed on the ASX, focused on developing medical imaging and diagnostic technologies. The company targets healthcare and biotechnology markets, providing investors exposure to emerging diagnostic solutions and related clinical applications.
Average Trading Volume: 1,754,263
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.3M
See more insights into IBX stock on TipRanks’ Stock Analysis page.